The USA’s Treat and Reduce Obesity Act

18 July 2016
medical_legal_law_big

By Dr Nicola Davies

The Treat and Reduce Obesity Act aims to improve access to weight management therapy. Over the last few years, obesity has become the hot button issue that legislators can set their sights on and pass meaningful legislation on without ruffling too many feathers, writes Dr Nicolas Davies in her monthly exclusive FDA Blog for The Pharma Letter. It seems that for the most part, lawmakers on both sides of the aisle are in favor of combating the disease that is proving to be a real strain on the health and finances of the country.

Obesity epidemic

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical